These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11570305)

  • 1. Current management of acute ischemic stroke. Part 2: Antithrombotics, neuroprotectives, and stroke units.
    Herd AM
    Can Fam Physician; 2001 Sep; 47():1795-800. PubMed ID: 11570305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window.
    Herd AM
    Can Fam Physician; 2001 Sep; 47():1787-93. PubMed ID: 11570304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
    J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Cornett O; Ocava LC; Singh M; Malhotra S; Rosenbaum DM
    Cardiol Clin; 2008 May; 26(2):251-65, vii. PubMed ID: 18406998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional stroke therapy: the potential benefit of direct intra-arterial infusion.
    Connors JJ
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S92-9. PubMed ID: 12556748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.
    Busch M; Masuhr F
    Eur J Med Res; 2004 Apr; 9(4):199-206. PubMed ID: 15210400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
    Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
    No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in the management of acute ischemic stroke.
    Sareen D
    J Assoc Physicians India; 2002 Mar; 50():407-14. PubMed ID: 11922233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].
    Murray V; Norrving B; Terént A; Wester P
    Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute ischemic stroke: role of ischemic tolerance in intravenous and endovascular therapies.
    Cornelius JF; Sandu N; Perez-Pinzon MA; Schaller B
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):331-2. PubMed ID: 19379055
    [No Abstract]   [Full Text] [Related]  

  • 19. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
    Douen AG; Medic S; Sabih M; Pageau N; Shuaib A
    J Stroke Cerebrovasc Dis; 2008; 17(6):356-9. PubMed ID: 18984426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.